TGFB1 and renal fibrosis: Consistent with these studies, we demonstrated that sorafenib reduced the rate of apoptosis and EMT in TGF-β-induced NRK-52E cells and ameliorated renal fibrosis in a UUO model, suggesting a potential and novel use of the drug in the treatment of renal fibrosis.